Published in Int J Evol Biol on August 18, 2014
A limit to the divergent allele advantage model supported by variable pathogen recognition across HLA-DRB1 allele lineages. Tissue Antigens (2015) 0.76
In vivo antimalarial activity of crude extracts and solvent fractions of leaves of Strychnos mitis in Plasmodium berghei infected mice. BMC Complement Altern Med (2017) 0.75
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 8.01
The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med (1976) 7.89
Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science (2001) 7.87
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet (2000) 7.25
Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis (1990) 7.11
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med (2006) 4.97
Pleistocene Homo sapiens from Middle Awash, Ethiopia. Nature (2003) 4.80
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe (2008) 4.55
Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science (2006) 4.35
Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet (2002) 4.23
Paediatric tuberculosis. Lancet Infect Dis (2008) 3.97
Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering? Ann Intern Med (1992) 3.56
Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med (1990) 3.38
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21
The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet (2000) 2.91
Genetics of susceptibility to human infectious disease. Nat Rev Genet (2001) 2.80
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis (2008) 2.77
Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet (1997) 2.77
Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol (2005) 2.50
Heritability of malaria in Africa. PLoS Med (2005) 2.49
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet (2011) 2.44
Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35
HLA and infectious diseases. Clin Microbiol Rev (2009) 2.35
Malaria in African children with deficient erythrocyte glucose-6-phosphate dehydrogenase. Br Med J (1961) 2.31
Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest (2005) 2.06
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01
Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet (2009) 1.94
Natural selection and resistance to HIV. Nature (2001) 1.93
G6PD deficiency: the genotype-phenotype association. Blood Rev (2007) 1.86
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J (2008) 1.85
Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med (Berl) (1998) 1.83
Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77
The origin of malaria: mixed messages from genetic diversity. Nat Rev Microbiol (2004) 1.68
Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Am J Hum Genet (2004) 1.61
Association of an HLA-DQ allele with clinical tuberculosis. JAMA (1998) 1.58
Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics (2006) 1.56
Population genomics: a bridge from evolutionary history to genetic medicine. Hum Mol Genet (2001) 1.49
Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis (2004) 1.43
The TB pandemic: an old problem seeking new solutions. J Intern Med (2007) 1.36
Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Genet (2004) 1.34
Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Am J Trop Med Hyg (2003) 1.31
The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV. Proc Natl Acad Sci U S A (2001) 1.28
Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol (1998) 1.28
Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res (2005) 1.24
Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tuber Lung Dis (1999) 1.22
Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis (2009) 1.21
Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci U S A (1994) 1.16
Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy. PLoS One (2008) 1.15
Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS (2000) 1.12
Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations. Eur J Hum Genet (2000) 1.11
Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics (2007) 1.03
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2013) 1.00
Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J Med Res (2000) 0.93
Cytokines inhibit the development of liver schizonts of the malaria parasite Plasmodium berghei in vivo. Eur J Immunol (1992) 0.92
Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya. J Infect Dis (2002) 0.92
Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia. AIDS Res Hum Retroviruses (2013) 0.88
Susceptibility to tuberculosis--the importance of the pathogen as well as the host. Clin Exp Immunol (2003) 0.85
Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population. AIDS Res Hum Retroviruses (2009) 0.85
CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans. BMC Infect Dis (2013) 0.83
Molecular subtypes of the HLA-DR antigens in pulmonary tuberculosis. Int J Infect Dis (2000) 0.83
A genome-wide association study primer for clinicians. Taiwan J Obstet Gynecol (2009) 0.82
Human genetics and malaria: relevance for the design of clinical trials. J Infect Dis (2008) 0.82
HLA antigen profile in pulmonary tuberculosis patients & their spouses. Indian J Med Res (1998) 0.80
Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals. Int J Infect Dis (2013) 0.78
Host genetics and the dissection of mycobacterial immunity. Clin Exp Immunol (2004) 0.75
Isolation and molecular characterization of Brucella isolates in cattle milk in Uganda. Biomed Res Int (2015) 0.88